You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ramucirumab

Showing 1 - 25 of 163
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • (no location specified)
Sep 12, 2023

Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])

Completed
  • Gastric Cancer
  • +2 more
  • Ramucirumab Injection
  • Ramucirumab Injection [Cyramza]
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab

Recruiting
  • Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
  • Cadonilimab Injection
  • Ramucirumab Injection
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 14, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 17, 2023

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Ramucirumab
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 21, 2022

Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Middletown, New Jersey
  • +5 more
Aug 17, 2023

Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
  • (no location specified)
Jun 7, 2023

Gastric Adenocarcinoma Trial in Guangzhou (Sintilimab, Ramucirumab, Cisplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • (no location specified)
Jan 9, 2023

Gastric Cancer Trial in Seoul (pembrolizumab plus ramucirumab)

Recruiting
  • Gastric Cancer
  • pembrolizumab plus ramucirumab
  • Seoul, Korea, Republic of
  • +1 more
Feb 23, 2022

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Ramucirumab
  • Somatostatin Analog
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 6, 2022

Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Tianjin (Serplulimab+Paclitaxel+Apatinib,

Recruiting
  • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 5, 2023

Transitional Cell Carcinoma Trial in New Haven (Pembrolizumab and Ramucirumab)

Withdrawn
  • Transitional Cell Carcinoma
  • Pembrolizumab and Ramucirumab
  • New Haven, Connecticut
    Yale University
Feb 18, 2022

Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Ramucirumab
  • TAS 102
  • Frankfurt, Germany
  • +4 more
Mar 2, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial (Poziotinib

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +3 more
  • Poziotinib Hydrochloride
  • 1429757-68-5, HM781-36B, NOV-1201 Hydrochloride, NOV120101 Hydrochloride, Poziotinib HCl, POZIOTINIB HYDROCHLORIDE
  • (no location specified)
Jul 18, 2022

NSCLC Stage IB, NSCLC Stage II, NSCLC Stage ?A Trial in Kashiwa, Shinjuku-Ku (Pembrolizumab, Ramucirumab, Surgery)

Recruiting
  • Non-small Cell Lung Cancer Stage IB
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 4, 2022

Malignant Solid Tumor Trial in United States (ramucirumab (IMC-1121B), paclitaxel)

Completed
Has Results
  • Malignant Solid Tumor
  • Ann Arbor, Michigan
  • +5 more
Feb 14, 2022

Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

Completed
  • Cholangiocarcinoma
  • +11 more
  • Laboratory Biomarker Analysis
  • Ramucirumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 7, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Circulating Angiogenic Factors for Second-line Paclitaxel and

Recruiting
  • Gastric Cancer Stage IV
    • Pisa, Italy
      University of Pisa
    Mar 28, 2022